In collaboration with Rullo lab (McMaster University, Hamilton, Canada) we developed and characterized a tunable multivalent synthetic platform that enables the recruitment of immune cells to PSMA-positive cancer cells expressing low levels of the target antigen.
![](http://lsb.avcr.cz/wp-content/uploads/2022/12/Thumb_Angewandte_2022-80x80.jpg)